- Home
- CCU vs KARD Comparison
CCU vs KARD Comparison
Compare CCU & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCU | KARD |
|---|---|---|
| Founded | 1850 | N/A |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCU | KARD |
|---|---|---|
| Price | $11.65 | $19.98 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 142.3K | ★ 256.4K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.42 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.71 | $19.58 |
| 52 Week High | $15.36 | $27.00 |
Technical Indicators
Market Signals| Indicator | CCU | KARD |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 42.71 |
| Support Level | $10.83 | $19.71 |
| Resistance Level | $11.95 | $24.82 |
| Average True Range (ATR) | 0.40 | 1.56 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 87.39 | 11.40 |
Price Performance
Historical ComparisonAbout CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About KARD Kardigan Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.